Xeris Pharmaceuticals | XERS - 销售毛利

金融业

USD

USD 392.01M

现金及等价物

USD 111.75M

USD 10.57M

USD 251.68M

USD 118.59M

USD 258.55M

USD 9.12M

USD 12.33M

377

EPS每股收益

USD 0.01

股本和储备

USD 13.01M

USD 72.55M

债务利息支出

USD 6.88M

USD 1.2M

USD 221.22M

USD 1.26B

USD 2.23M

USD 75.21M

USD 7.92M

普通股股本

USD 172.56M

76.05

USD 2.23M

USD 83.13M

销售和管理费用

USD 53.14M

USD 74.23M

贸易债权人

USD 11.47M

应收帐款人

USD 56.3M

	销售毛利	更改		日
Celltrion	KRW 39.29B		7.7B	2026-03
Cspc Pharmaceutical	CNY 4.01B		329.18M	2025-12
Deva Holding AS	TRY 1.32B		235.77M	2023-09
Dianthus Therapeutics	USD 463K		179K	2026-03
Divis Laboratories Ltd	INR 16.59B		2.05B	2025-12
Eli Lilly	USD 15.92B		1.33B	2025-12
Kangmei Pharma	CNY 238.34M		31.95M	2026-03
Knight Therapeutics	CAD 64.72M		8.91M	2025-12
Laboratorios Farma	EUR 105.28M		177.08M	2025-06
Medical Developments International	AUD 7.35M		7.37M	2025-06
Nektar Therapeutics	USD 21.81M		8.06M	2025-12
Neuren Pharmaceuticals	AUD 6.69M		6.37M	2025-06
Organigram Holdings	CAD 16.41M		6.91M	2026-03
Pacira	USD 126.64M		15.61M	2026-03
Perrigo	USD 325.5M		36.7M	2026-03
Pharma Mar	EUR 39.24M		47.46M	2026-03
Qiagen NV	USD 325.27M		19.53M	2025-12
Sartorius	EUR 414.5M		18.3M	2026-03
Sino Biopharmaceutical	CNY 10.5B		2.53B	2024-12
Supernus Pharmaceuticals	USD 129.36M		34.68M	2026-03
Tilray	USD 57.47M		10.16M	2025-06
Zealand Pharma A/S	68.91M		19.35M	2025-12
Zz Pientze Pharmaceu	CNY 1.16B		860.2M	2026-03